✦ LIBER ✦

OP47 Efficacy and safety of spironolactone on proteinuria in chronic kidney disease patients in Yaounde: open-label randomized clinical trial

✍ Scribed by Ngatchou, N.; Ashuntantang, G.; Menanga, A.P.; Kaze, F.J. Folefack; Sobngwi, E.; Kingue, S.

Book ID: 122160873
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 78 KB
Volume: 103
Category: Article
ISSN: 0168-8227
DOI: 10.1016/S0168-8227(14)70070-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of eltrombopag in Ja

Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study

✍ Takumi Kawaguchi, Atsumasa Komori, Masataka Seike, Shigetoshi Fujiyama, Hiroshi 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 324 KB

Efficacy, safety and tolerability of ong

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial

✍ Chih-Chieh Yu, Wen-Ter Lai, Kuang-Chung Shih, Tsung-Hsien Lin, Chieh-Hua Lu, Hun 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

A single-center open label randomized tr

A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients—preliminary results

✍ P.G.P Machado; C Garcia; C.R Felipe; R Garcia; M Franco; R Delcelo; H.T Silva Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A 51-week, open-label clinical trial in

A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis

✍ Ramesh, Hariharan; Reddy, Nageshwar; Bhatia, Shobna; Rajkumar, J.S.; Bapaye, Amo 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 481 KB

A Multicenter, Prospective, Open Label,

A Multicenter, Prospective, Open Label, Historically Controlled Clinical Trial to Evaluate Efficacy and Safety in Primary Immunodeficiency Diseases (PID) Patients of Flebogamma®5% DIF, the Next Generation of Flebogamma®

✍ Melvin Berger; The Flebogamma® 5% DIF Investigators 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 126 KB

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views